Product
Use Cases
Security
Resources
Log In
Request Demo
Research
/
Companies
/
4D Molecular Therapeutics, Inc.
/
Q1 2026 earnings
Earnings summary
4D Molecular Therapeutics, Inc.
Q1 2026
results
Revenue
$3M
YoY growth
+21664.3%
Diluted EPS
$-1.01
Operating margin
-2416.1%
More on 4D Molecular Therapeutics, Inc.
Company
4D Molecular Therapeutics, Inc. overview
Facet
Financials
See how
VectorShift
works for your firm
Request Demo
×